SAFETY OF RHGH IN UNTREATED PATIENTS WITH GROWTH HORMONE DEFICIENCY

RHGH 在未经治疗的生长激素缺乏症患者中的安全性

• 批准号: 3743455
• 负责人: ROBERT M BLIZZARD
• 金额: --
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3743455
• 关键词: drug screening /evaluation; endocrine disorder chemotherapy; endocrine pharmacology; hormone therapy; human subject; human therapy evaluation; pituitary dwarfism; recombinant proteins; somatotropin

The goal is to demonstrate the safety and effectiveness of recombinant human growth hormone (rhGH) in the treatment of growth failure due to GH deficiency. These patients will receive rhGH. The efficacy and toxicity of GH will be studied.

目的是证明重组的安全性和有效性 人类生长激素（RHGH）在治疗GH引起的生长失败方面 不足。 这些患者将接受RHGH。 功效和毒性 将研究GH的。